Yoshihara T

No ORCID on file · 4 papers in corpus
2026
Pregnancy outcomes of patients with retained products of conception following miscarriage treated with relugolix, an oral gonadotropin-releasing hormone antagonist.
Frontiers in medicine ·doi:10.3389/fmed.2026.1704529

BackgroundRelugolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, represents a potentially effective and less invasive therapeutic approach for retained products of conception (RPOC). However, its impact on subsequent pregnancy…

article 2026
Subtype-specific analysis of factors associated with assisted reproductive technology indication and live birth in patients with adenomyosis: a retrospective study
Archives of gynecology and obstetrics ·doi:10.1007/s00404-026-08490-4

PURPOSE: The magnetic resonance imaging (MRI)-based classification of adenomyosis subtypes helps predict reproductive and obstetric outcomes; however, background factors associated with use of assisted reproductive technology (ART) and live…

article 2023
Endometrioid adenocarcinoma arising from inguinal endometriosis during follow-up for gastric cancer surgery: a case report and literature review
International cancer conference journal ·doi:10.1007/s13691-023-00639-1

Malignant transformation of inguinal endometriosis is rare. A 56-year-old woman underwent surgery for advanced gastric cancer 5 years ago and received postoperative adjuvant chemotherapy. She had no recurrence since then. However, 5 years a…

other 1999
Prognostic factors relating to survival in uterine endometrioid carcinoma
International Journal of Gynecology & Obstetrics ·doi:10.1016/s0020-7292(99)00067-3

OBJECTIVE: Epidemiologic and clinicohistopathologic prognostic factors of uterine endometrioid carcinomas were analyzed. The association of estrogen related factors, focused on adenomyosis in the prognosis of endometrioid carcinomas was als…